The endotherapy devices market size has grown strongly in recent years. It will grow from $4.87 billion in 2025 to $5.24 billion in 2026 at a compound annual growth rate (CAGR) of 7.6%. The growth in the historic period can be attributed to growth in gastrointestinal disorder prevalence, expansion of endoscopy infrastructure, increasing adoption of minimally invasive surgical techniques, availability of advanced therapeutic endoscopes, rising demand for outpatient endoscopic treatments.
The endotherapy devices market size is expected to see strong growth in the next few years. It will grow to $7.12 billion in 2030 at a compound annual growth rate (CAGR) of 8%. The growth in the forecast period can be attributed to increasing investments in advanced endoscopy platforms, rising adoption of therapeutic endoscopic interventions, expansion of precision-guided endotherapy, growing demand for faster recovery procedures, increasing integration of ai-assisted endoscopy. Major trends in the forecast period include increasing adoption of advanced endoscopic treatment devices, rising use of minimally invasive endotherapy procedures, growing integration of electrosurgical and ablation technologies, expansion of therapeutic endoscopy applications, enhanced focus on procedure precision and safety.
The growth of the endotherapy devices market is further fueled by the rising prevalence of obesity. Obesity, characterized by the excessive accumulation of body fat with adverse effects on health, can be effectively managed with endotherapy devices. These devices play a crucial role in weight loss, appetite reduction, improving the quality of life, providing minimally invasive treatment, and offering temporary interventions for obesity management. According to World Obesity, the number of obese individuals is expected to increase to 892 million in 2025 and reach 1.02 billion in 2030. Consequently, the growing prevalence of obesity is a key driver for the expansion of the endotherapy devices market.
Key companies in the endotherapy devices market are developing innovative solutions, such as red dichromatic imaging (RDI), to improve the visualization of blood vessels and bleeding sites during endoscopic procedures. RDI enhances the visibility of blood vessels and lesions by utilizing two different wavelengths of light, which improves diagnostic accuracy during procedures. For example, in October 2023, Olympus Corporation, a medical technology company based in Japan, launched the EVIS X1 endoscopy system. This cutting-edge system integrates advanced imaging technologies and artificial intelligence to enhance visualization and diagnostic capabilities. The EVIS X1 features texture and color enhancement imaging (TXI), which improves the visibility of lesions and polyps by enhancing their color and texture. Additionally, RDI focuses on deep blood vessels and bleeding points, while brightness adjustment imaging with maintenance of contrast (BAI-MAC) ensures balanced brightness levels throughout the image.
In January 2024, Olympus Corporation, a medical technology company based in Japan, acquired Taewoong Medical Co. Ltd. for an undisclosed sum. This acquisition allows Olympus to improve patient outcomes by providing a wider range of clinically differentiated technologies, thereby elevating the standard of care in gastrointestinal treatments. Taewoong Medical Co. Ltd. is a manufacturer located in South Korea that specializes in medical devices, including gastrointestinal (GI) metallic stents.
Major companies operating in the endotherapy devices market are Olympus Corporation, Boston Scientific Corporation, Medtronic plc, CONMED Corporation, Fujifilm Holdings Corporation, Karl Storz SE & Co. KG, Cook Medical Incorporated, Taewoong Medical Co. Ltd., Micro-Tech (Nanjing) Co. Ltd., B. Braun Melsungen AG, Pentax Medical, Nipro Corporation, Richard Wolf GmbH, Cogentix Medical Inc., Endogastric Solutions Inc., Gyrus ACMI, Cantel Medical Corp., Smith & Nephew plc, Stryker Corporation, HOYA Corporation, Steris Corporation.
North America as the largest region in the endotherapy devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global endotherapy devices market report during the forecast period. The regions covered in the endotherapy devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the endotherapy devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the endotherapy devices market by increasing costs of imported endoscopic instruments, imaging components, electrosurgical tools, and precision accessories used in therapeutic procedures. Hospitals and ambulatory surgical centers in North America and Europe are most affected due to reliance on imported high-end devices, while Asia-Pacific faces higher manufacturing input costs. These tariffs are increasing capital expenditure for endoscopy units. However, they are also encouraging domestic device production, regional innovation, and localized supply chain development.
The endotherapy devices market research report is one of a series of new reports that provides endotherapy devices market statistics, including endotherapy devices industry global market size, regional shares, competitors with a endotherapy devices market share, detailed endotherapy devices market segments, market trends and opportunities, and any further data you may need to thrive in the endotherapy devices industry. This endotherapy devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Endotherapy devices are medical instruments employed in endoscopic procedures aimed at diagnosing, treating, and managing various disorders across different medical fields such as gastrointestinal, colonoscopy, laparoscopy, anoscopy, arthroscopy, bronchoscopy, and others. These devices are specifically designed for use in conjunction with an endoscope, a flexible tube equipped with a light and camera that enables physicians to visually inspect the internal organs more effectively.
The primary categories of endotherapy devices include gastrointestinal devices and accessories, endoscopic retrograde cholangiopancreatography devices and accessories, and other endotherapy devices. Gastrointestinal devices and accessories are medical tools utilized in the diagnosis and treatment of gastrointestinal (GI) disorders. They play a crucial role in various procedures, including endoscopic examinations that allow visualization and access to the inside of the GI tract, covering areas such as the esophagus, stomach, duodenum, and colon. Additionally, these devices are employed in surgical interventions to deliver targeted therapies directly to affected areas. These devices find extensive applications in bronchoscopy, arthroscopy, laparoscopy, urology endoscopy, neuro-endoscopy, gastrointestinal endoscopy, and other medical procedures performed by hospitals, ambulatory surgical centers, and other end-users.
The endotherapy devices market consists of sales of devices such as mechanically enhanced colonoscopies, endoscopic hemostasis, tissue sampling devices, metallic stents, dilation balloons, foreign body retrieval devices, electrosurgical needs, and UCR insufflators. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The endotherapy devices market size is expected to see strong growth in the next few years. It will grow to $7.12 billion in 2030 at a compound annual growth rate (CAGR) of 8%. The growth in the forecast period can be attributed to increasing investments in advanced endoscopy platforms, rising adoption of therapeutic endoscopic interventions, expansion of precision-guided endotherapy, growing demand for faster recovery procedures, increasing integration of ai-assisted endoscopy. Major trends in the forecast period include increasing adoption of advanced endoscopic treatment devices, rising use of minimally invasive endotherapy procedures, growing integration of electrosurgical and ablation technologies, expansion of therapeutic endoscopy applications, enhanced focus on procedure precision and safety.
The growth of the endotherapy devices market is further fueled by the rising prevalence of obesity. Obesity, characterized by the excessive accumulation of body fat with adverse effects on health, can be effectively managed with endotherapy devices. These devices play a crucial role in weight loss, appetite reduction, improving the quality of life, providing minimally invasive treatment, and offering temporary interventions for obesity management. According to World Obesity, the number of obese individuals is expected to increase to 892 million in 2025 and reach 1.02 billion in 2030. Consequently, the growing prevalence of obesity is a key driver for the expansion of the endotherapy devices market.
Key companies in the endotherapy devices market are developing innovative solutions, such as red dichromatic imaging (RDI), to improve the visualization of blood vessels and bleeding sites during endoscopic procedures. RDI enhances the visibility of blood vessels and lesions by utilizing two different wavelengths of light, which improves diagnostic accuracy during procedures. For example, in October 2023, Olympus Corporation, a medical technology company based in Japan, launched the EVIS X1 endoscopy system. This cutting-edge system integrates advanced imaging technologies and artificial intelligence to enhance visualization and diagnostic capabilities. The EVIS X1 features texture and color enhancement imaging (TXI), which improves the visibility of lesions and polyps by enhancing their color and texture. Additionally, RDI focuses on deep blood vessels and bleeding points, while brightness adjustment imaging with maintenance of contrast (BAI-MAC) ensures balanced brightness levels throughout the image.
In January 2024, Olympus Corporation, a medical technology company based in Japan, acquired Taewoong Medical Co. Ltd. for an undisclosed sum. This acquisition allows Olympus to improve patient outcomes by providing a wider range of clinically differentiated technologies, thereby elevating the standard of care in gastrointestinal treatments. Taewoong Medical Co. Ltd. is a manufacturer located in South Korea that specializes in medical devices, including gastrointestinal (GI) metallic stents.
Major companies operating in the endotherapy devices market are Olympus Corporation, Boston Scientific Corporation, Medtronic plc, CONMED Corporation, Fujifilm Holdings Corporation, Karl Storz SE & Co. KG, Cook Medical Incorporated, Taewoong Medical Co. Ltd., Micro-Tech (Nanjing) Co. Ltd., B. Braun Melsungen AG, Pentax Medical, Nipro Corporation, Richard Wolf GmbH, Cogentix Medical Inc., Endogastric Solutions Inc., Gyrus ACMI, Cantel Medical Corp., Smith & Nephew plc, Stryker Corporation, HOYA Corporation, Steris Corporation.
North America as the largest region in the endotherapy devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global endotherapy devices market report during the forecast period. The regions covered in the endotherapy devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the endotherapy devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the endotherapy devices market by increasing costs of imported endoscopic instruments, imaging components, electrosurgical tools, and precision accessories used in therapeutic procedures. Hospitals and ambulatory surgical centers in North America and Europe are most affected due to reliance on imported high-end devices, while Asia-Pacific faces higher manufacturing input costs. These tariffs are increasing capital expenditure for endoscopy units. However, they are also encouraging domestic device production, regional innovation, and localized supply chain development.
The endotherapy devices market research report is one of a series of new reports that provides endotherapy devices market statistics, including endotherapy devices industry global market size, regional shares, competitors with a endotherapy devices market share, detailed endotherapy devices market segments, market trends and opportunities, and any further data you may need to thrive in the endotherapy devices industry. This endotherapy devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Endotherapy devices are medical instruments employed in endoscopic procedures aimed at diagnosing, treating, and managing various disorders across different medical fields such as gastrointestinal, colonoscopy, laparoscopy, anoscopy, arthroscopy, bronchoscopy, and others. These devices are specifically designed for use in conjunction with an endoscope, a flexible tube equipped with a light and camera that enables physicians to visually inspect the internal organs more effectively.
The primary categories of endotherapy devices include gastrointestinal devices and accessories, endoscopic retrograde cholangiopancreatography devices and accessories, and other endotherapy devices. Gastrointestinal devices and accessories are medical tools utilized in the diagnosis and treatment of gastrointestinal (GI) disorders. They play a crucial role in various procedures, including endoscopic examinations that allow visualization and access to the inside of the GI tract, covering areas such as the esophagus, stomach, duodenum, and colon. Additionally, these devices are employed in surgical interventions to deliver targeted therapies directly to affected areas. These devices find extensive applications in bronchoscopy, arthroscopy, laparoscopy, urology endoscopy, neuro-endoscopy, gastrointestinal endoscopy, and other medical procedures performed by hospitals, ambulatory surgical centers, and other end-users.
The endotherapy devices market consists of sales of devices such as mechanically enhanced colonoscopies, endoscopic hemostasis, tissue sampling devices, metallic stents, dilation balloons, foreign body retrieval devices, electrosurgical needs, and UCR insufflators. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Endotherapy Devices Market Characteristics
3. Endotherapy Devices Market Supply Chain Analysis
4. Global Endotherapy Devices Market Trends and Strategies
5. Endotherapy Devices Market Analysis of End Use Industries
7. Global Endotherapy Devices Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Endotherapy Devices Total Addressable Market (TAM) Analysis for the Market
9. Endotherapy Devices Market Segmentation
10. Endotherapy Devices Market Regional and Country Analysis
11. Asia-Pacific Endotherapy Devices Market
12. China Endotherapy Devices Market
13. India Endotherapy Devices Market
14. Japan Endotherapy Devices Market
15. Australia Endotherapy Devices Market
16. Indonesia Endotherapy Devices Market
17. South Korea Endotherapy Devices Market
18. Taiwan Endotherapy Devices Market
19. South East Asia Endotherapy Devices Market
20. Western Europe Endotherapy Devices Market
21. UK Endotherapy Devices Market
22. Germany Endotherapy Devices Market
23. France Endotherapy Devices Market
24. Italy Endotherapy Devices Market
25. Spain Endotherapy Devices Market
26. Eastern Europe Endotherapy Devices Market
27. Russia Endotherapy Devices Market
28. North America Endotherapy Devices Market
29. USA Endotherapy Devices Market
30. Canada Endotherapy Devices Market
31. South America Endotherapy Devices Market
32. Brazil Endotherapy Devices Market
33. Middle East Endotherapy Devices Market
34. Africa Endotherapy Devices Market
36. Endotherapy Devices Market Competitive Landscape and Company Profiles
37. Endotherapy Devices Market Other Major and Innovative Companies
40. Endotherapy Devices Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Endotherapy Devices Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses endotherapy devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for endotherapy devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The endotherapy devices market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product: Gastrointestinal Devices and Accessories; Endoscopic Retrograde Cholangio Pancreatography Devices And Accessories; Other Endotherapy Devices2) By Application: Bronchoscopy; Arthroscopy; Laparoscopy; Urology Endoscopy; Neuro-Endoscopy; Gastrointestinal Endoscopy; Other Applications
3) By End-Use: Hospital; Ambulatory Surgical Centers; Other End-Users
Subsegments:
1) By Gastrointestinal Devices And Accessories: Endoscopic Mucosal Resection (EMR) Devices; Endoscopic Submucosal Dissection (ESD) Devices; Biopsy Forceps; Clips And Closure Devices; Electrosurgical Devices2) By Endoscopic Retrograde Cholangio Pancreatography (ERCP) Devices And Accessories: ERCP Cannulas; Balloon Sweep Devices; Stents; Guidewires; Sphincterotomes
3) By Other Endotherapy Devices: Endoscopic Ultrasound (EUS) Devices; Ablation Devices; Foreign Body Retrieval Devices; Laser Therapy Devices
Companies Mentioned: Olympus Corporation; Boston Scientific Corporation; Medtronic plc; CONMED Corporation; Fujifilm Holdings Corporation; Karl Storz SE & Co. KG; Cook Medical Incorporated; Taewoong Medical Co. Ltd.; Micro-Tech (Nanjing) Co. Ltd.; B. Braun Melsungen AG; Pentax Medical; Nipro Corporation; Richard Wolf GmbH; Cogentix Medical Inc.; Endogastric Solutions Inc.; Gyrus ACMI; Cantel Medical Corp.; Smith & Nephew plc; Stryker Corporation; HOYA Corporation; Steris Corporation
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Endotherapy Devices market report include:- Olympus Corporation
- Boston Scientific Corporation
- Medtronic plc
- CONMED Corporation
- Fujifilm Holdings Corporation
- Karl Storz SE & Co. KG
- Cook Medical Incorporated
- Taewoong Medical Co. Ltd.
- Micro-Tech (Nanjing) Co. Ltd.
- B. Braun Melsungen AG
- Pentax Medical
- Nipro Corporation
- Richard Wolf GmbH
- Cogentix Medical Inc.
- Endogastric Solutions Inc.
- Gyrus ACMI
- Cantel Medical Corp.
- Smith & Nephew plc
- Stryker Corporation
- HOYA Corporation
- Steris Corporation
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 5.24 Billion |
| Forecasted Market Value ( USD | $ 7.12 Billion |
| Compound Annual Growth Rate | 8.0% |
| Regions Covered | Global |
| No. of Companies Mentioned | 22 |
